Molecularly targeted therapy: When to stop and when to continue?

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Access to Document

@article{7472434d202e4f2ab3afac7b9516144c,

title = "Molecularly targeted therapy: When to stop and when to continue?",

author = "Hirsch, \{Fred R.\} and Mok, \{Tony S.\} and Virginia Borges and Bunn, \{Paul A.\}",

year = "2010",

month = aug,

doi = "10.1016/S1470-2045(10)70128-5",

language = "English",

volume = "11",

pages = "709--711",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "8",

}

TY - JOUR

T1 - Molecularly targeted therapy

T2 - When to stop and when to continue?

AU - Hirsch, Fred R.

AU - Mok, Tony S.

AU - Borges, Virginia

AU - Bunn, Paul A.

PY - 2010/8

Y1 - 2010/8

UR - https://www.scopus.com/pages/publications/77955281431

U2 - 10.1016/S1470-2045(10)70128-5

DO - 10.1016/S1470-2045(10)70128-5

M3 - Comment/debate

C2 - 20570560

AN - SCOPUS:77955281431

SN - 1470-2045

VL - 11

SP - 709

EP - 711

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -